4.6 Review

COVID-19: disease, or no disease? - that is the question. It's the dose stupid!

期刊

MICROBES AND INFECTION
卷 23, 期 1, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.micinf.2021.104779

关键词

Covid-19; Dose; Innate immunity; Galectins

资金

  1. NIH 2020 R21 AI [5R21AI142862-02]
  2. NIH 2020 R01 [EY5R01EY00509335]

向作者/读者索取更多资源

The dose and presentation of the infecting virus play a crucial role in determining the outcomes of COVID-19 infection, with higher doses potentially leading to more severe consequences. Further research and testing are needed to explore practical maneuvers and untested procedures that aim to increase the threshold dose required to break through resistance barriers.
The COVID-19 pandemic has raised many issues not the least of which is the reason for its high variability in consequences to the infected person. In this opinion letter, we advocate that the dose and presentation of the infecting virus is a major factor that affects whether the outcome is subclinical, tissue damaging or even lethal following infection. We briefly describe the known effects of virus dose on the course COVID-19 and discuss practical maneuvers as well as largely untested procedures that can raise the threshold dose needed to break through barriers of resistance. (C) 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据